Boston Partners Sells 352,479 Shares of Quipt Home Medical Corp. (NASDAQ:QIPT)

Boston Partners trimmed its position in shares of Quipt Home Medical Corp. (NASDAQ:QIPT) by 61.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 218,820 shares of the company’s stock after selling 352,479 shares during the quarter. Boston Partners owned 0.51% of Quipt Home Medical worth $667,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Atom Investors LP bought a new position in shares of Quipt Home Medical during the 3rd quarter valued at $51,000. XTX Topco Ltd bought a new position in Quipt Home Medical in the 3rd quarter worth $54,000. JPMorgan Chase & Co. raised its holdings in Quipt Home Medical by 68.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 30,403 shares of the company’s stock worth $89,000 after purchasing an additional 12,383 shares during the period. Los Angeles Capital Management LLC bought a new position in Quipt Home Medical in the 4th quarter worth $104,000. Finally, Raymond James Financial Inc. bought a new position in Quipt Home Medical in the 4th quarter worth $113,000. 42.85% of the stock is owned by institutional investors.

Quipt Home Medical Price Performance

Shares of Quipt Home Medical stock opened at $2.37 on Friday. Quipt Home Medical Corp. has a one year low of $2.23 and a one year high of $4.43. The stock’s fifty day moving average is $2.77 and its 200 day moving average is $2.75. The stock has a market cap of $102.13 million, a P/E ratio of -13.94 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.87 and a current ratio of 1.22.

Quipt Home Medical (NASDAQ:QIPT) last announced its earnings results on Monday, February 10th. The company reported ($0.03) EPS for the quarter. Quipt Home Medical had a negative return on equity of 6.70% and a negative net margin of 2.90%. Sell-side analysts anticipate that Quipt Home Medical Corp. will post -0.05 earnings per share for the current year.

Insider Buying and Selling

In other Quipt Home Medical news, VP Patrick Dennis Gamble purchased 17,000 shares of the firm’s stock in a transaction on Thursday, December 26th. The shares were acquired at an average cost of $2.45 per share, with a total value of $41,650.00. Following the completion of the acquisition, the vice president now directly owns 40,057 shares in the company, valued at $98,139.65. The trade was a 73.73 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. 13.40% of the stock is owned by insiders.

About Quipt Home Medical

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.